Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FKNPL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,165
Award facts
- Contract value 100% obligated
- $48,164.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg with a ceiling value of $48,164.93. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems. Otezla (apremilast) is an oral immunomodulatory agent used to treat conditions such as plaque psoriasis, psoriatic arthritis, and Behçet's disease. This delivery order reflects AmerisourceBergen's role as a critical vendor within the DLA Medical Supply Chain, providing both brand-name medications and generic pharmaceuticals to support the Defense Health Agency and other federal healthcare customers worldwide. The contract received no set-aside designation, indicating it was awarded through open competition.
Quick answers
Who was awarded contract SPE2DB25FKNPL?
SPE2DB25FKNPL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FKNPL worth?
The government has obligated $48,165 on SPE2DB25FKNPL.
Is contract SPE2DB25FKNPL an order under another contract?
Yes. SPE2DB25FKNPL is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKNPL competed?
The extent of competition for SPE2DB25FKNPL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award